NEW YORK (GenomeWeb) – Focus Diagnostics today announced its Simplexa Group A Strep Direct kit has received 510(k) clearance from the US Food and Drug Administration for marketing in the US. 

The agency has also categorized the test as moderate complexity, which will allow some clinicians to perform the test directly. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.